NeoGenomics, Inc.
(NASDAQ : NEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
GHGuardant Health, Inc. 2.80%112.840.0%$104.49m
NVTAInvitae Corp. 6.29%27.731.2%$101.98m
DVADaVita, Inc. -0.32%125.543.7%$86.12m
NTRANatera, Inc. 4.80%93.191.2%$84.78m
FLGTFulgent Genetics, Inc. 4.29%70.340.6%$74.15m
OSHOak Street Health, Inc. 4.51%55.900.0%$67.20m
AMEDAmedisys, Inc. 2.56%256.9711.4%$47.93m
AGLAgilon Health, Inc. 2.95%30.000.0%$44.85m
CHEChemed Corp. 0.02%482.5610.1%$44.66m
SDCSmileDirectClub, Inc. 2.37%7.780.0%$42.00m
ONEM1Life Healthcare, Inc. -0.14%32.760.0%$38.22m
NEONeoGenomics, Inc. 4.07%38.115.3%$32.79m
ACHCAcadia Healthcare Co., Inc. 3.31%65.6226.9%$29.38m
LHCGLHC Group, Inc. 1.39%188.592.9%$29.37m
MDMEDNAX, Inc. 2.01%31.4811.0%$25.18m

Company Profile

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.